Moderna, Inc. (MRNA) — QMA analysis
Sector: Healthcare · Market cap: $16.1B · Price: $200.1 · Data as of 2026-10-23
A composite score of 48/100 places Moderna, Inc. in the neutral band, higher score than 66% of 22,733 tracked stocks. The highest-scoring layer is Relative strength; the lowest is Insider activity.
What 6 data layers say about MRNA
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 29/100 |
| Technical trend (TSS) | 66/100 |
| Relative strength (RS) | 98/100 |
| Momentum (USS) | 53/100 |
| Insider activity (IAS) | 10/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 82/100 |
What does the QMA model currently show for Moderna, Inc.?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For MRNA the layers diverge — some score high (Relative strength), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
MRNA insider & smart money activity
Over the recent period we record 10 reported insider purchases and 41 sales for MRNA: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.
MRNA seasonality
The historically strong window for MRNA comes up November 1–28 with a hit rate of 86% and an average move of 23.0% (9 years of history).
Historical data does not guarantee future results.
How MRNA compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for MRNA stock?
48/100 (C) — Data as of 2026-10-23.
Are insiders buying MRNA stock?
Over the recent period, reported: purchases 10, sales 41 (purchases $20M, sales $65.2M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.
Where can I see live MRNA data?
Live MRNA data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]